# Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

> **NCT02554240** · PHASE2 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 115 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** DA-5202 20mg
- **DRUG:** DA-5202 10mg
- **DRUG:** Na Hyaluronate 20mg

## Key facts

- **NCT ID:** NCT02554240
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-23
- **Primary completion:** 2016-06-29
- **Final completion:** 2016-10-14
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02554240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02554240, "Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02554240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*